Unified Patent Court (UPC) analytics are now available. Check here

Law FirmOpposition Filing Analysis

The comprehensive analysis of Wilk opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Wilk

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3324979Infectious Disease VaccinesMODERNATXJul 10, 2023BIONTECH
EP2791160Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA THERAPEUTICSDec 2, 2022BIONTECH
EP3590949Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNATXSep 23, 2022BIONTECH
EP3134131Nucleic Acid VaccinesMODERNATXSep 22, 2022BIONTECH
EP3682905Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNATXAug 29, 2022BIONTECH
EP2976418A Method For Producing A Product (E.G. Polypeptide) In A Continuous Cell Culture Fermentation Process.CMC BIOLOGICSJun 30, 2021WILK
EP3492109Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNA THERAPEUTICSDec 4, 2020BIONTECH
EP3170842Immunologic Effector Cell Of Targeted Cld18A2, And Preparation Method And Use ThereofCARSGEN THERAPEUTICSJun 4, 2020BIONTECH CELL & GENE THERAPIES
EP3153179Optimised Injection Formulation For MrnaCUREVACMar 16, 2020BIONTECH
EP2115043Paek Powder, Particularly For Use In A Method For The Production Of A Three-Dimensional Object In Layers, And Method For The Production ThereofEOS ELECTRO OPTICAL SYSTEMSFeb 28, 2018VICTREX MANUFACTURING

Top companies who are the clients of Wilk